BIOBIJOU Co.,Ltd.: what insiders have been doing
Only a handful of insider records exist for BIOBIJOU Co.,Ltd., too few to describe a trend. These figures are compiled from regulatory filings published by DART (FSS). They describe what insiders did and are not a recommendation.
Insider Decl.
n/a
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Fundamental score
Ranked 12,522 of 26,911 companies
53.3
score / 100
Value28
Quality79
FCF yld-1.8%
Earn yld2.1%
EV/EBITDA33.8x
ROE10%
Gross mgn56%
Net mgn15%
Debt/EBITDA0.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
₩11,720
Analyst consensus
Income statement
Revenue₩28.5B
Gross profit₩15.9B56% margin
EBITDA₩5.8B20% margin
Net income₩4.2B22.8% margin
Balance sheet & cash
Market cap₩172.9B
Total debt₩373.5M
Free Cash Flow-₩3.6B
Debt / Equity1%
Profitability & ownership
ROE10.4%
ROA4.7%
% insiders88.3%
% institutions0.1%
Declarations1 total
- Other0DART
1 of 1 declaration
About BIOBIJOU Co.,Ltd.
BioVisu is a company listed on the XKRX market, specializing in the biotechnology sector. It focuses on developing innovative solutions for the healthcare industry.